Slapnicar, C. et al. 2026. Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita. Journal of Hematology. (Mar. 2026). DOI:https://doi.org/10.14740/jh2160.